Answers are grounded in this paper and cite their sources.
Retrospective study compares five LDL-apheresis techniques in severe familial hypercholesterolemia, showing safe long-term lipid reduction without meeting time-averaged target levels.
PURPOSE: To compare long-term efficacy and biocompatibility of the 5 most commonly applied LDL-apheresis techniques using a specifically modified calculation method of the area under the curve (AUC) for laboratory parameters. DESIGN: Retrospective long-term analysis of 20 patients with homozygous or severe heterozygous familial hypercholesterolemia. PROCEDURES: The following 5 extra-corporeal LDL-apheresis methods were compared: IMAL (Immuno Adsorption of Lipoproteins), DSA (Dextran Sulphate Adsorption), HELP (Heparin Induced Extra-corporeal LDL Precipitation), DALI (Direct Adsorption of Lipoproteins), MDF (Membrane Differential Filtration). MAIN OUTCOME MEASURES: AUC derived plasma concentrations (C(AUC)) of lipoproteins between two apheresis procedures and their long-term course. Comparison of biocompatibility and efficacy concerning the LDL-C target of < 2.6 mmol/L of 5 apheresis techniques. Progression of atherosclerosis in patients with severe hypercholesterolemia. MAIN FINDINGS: The means of AUC derived average plasma concentrations (C(AUC)) of all treatment intervals were for LDL-C and the LDL/HDL ratio as follows: IMAL (5.59 mmol/L; ratio 4.1), DSA (3.03 mmol/L; ratio 2.0), HELP (4.06 mmol/L; ratio 2.2), DALI (3.83 mmol/L; ratio 3.3), MDF (3.26 mmol/L; ratio 3.2). Coronary heart disease and cardiac events (myocardial infarction, PTCA/ stent implantation, CABG) progressed in only 2 patients whereas atherosclerosis manifestations (sclerosis abdominal aorta, carotid artery stenosis, peripheral vascular disease) worsened in 13 patients. Mean ergometric capacity improved from 112 to 118 Watt. CONCLUSIONS: All 5 apheresis methods (IMAL, DSA, HELP, DALI, MDF) proved to be safe and suitable for long-term treatment in patients with severe hypercholesterolemia. The introduction of the C(AUC) revealed that the target of LDL-C < 2.6 mmol/L was not achieved with regard to the time averaged concentration (C(AUC)).
No takes yet. Share an insight, caveat, or question.
Krebs et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: